Literature DB >> 33221895

Brugada syndrome genetics is associated with phenotype severity.

Giuseppe Ciconte1, Michelle M Monasky1, Vincenzo Santinelli1, Emanuele Micaglio1, Gabriele Vicedomini1, Luigi Anastasia2,3, Gabriele Negro1, Valeria Borrelli1, Luigi Giannelli1, Francesca Santini1, Carlo de Innocentiis1, Roberto Rondine1, Emanuela T Locati1, Andrea Bernardini1, Beniamino C Mazza1, Valerio Mecarocci1, Žarko Ćalović1, Andrea Ghiroldi2, Sara D'Imperio2, Sara Benedetti4, Chiara Di Resta3,4, Ilaria Rivolta5, Giorgio Casari3,4, Enrico Petretto6, Carlo Pappone1,3.   

Abstract

AIMS: Brugada syndrome (BrS) is associated with an increased risk of sudden cardiac death due to ventricular tachycardia/fibrillation (VT/VF) in young, otherwise healthy individuals. Despite SCN5A being the most commonly known mutated gene to date, the genotype-phenotype relationship is poorly understood and remains uncertain. This study aimed to elucidate the genotype-phenotype correlation in BrS. METHODS AND
RESULTS: Brugada syndrome probands deemed at high risk of future arrhythmic events underwent genetic testing and phenotype characterization by the means of epicardial arrhythmogenic substrate (AS) mapping, and were divided into two groups according to the presence or absence of SCN5A mutation. Two-hundred probands (160 males, 80%; mean age 42.6 ± 12.2 years) were included in this study. Patients harbouring SCN5A mutations exhibited a spontaneous type 1 pattern and experienced aborted cardiac arrest or spontaneous VT/VF more frequently than the other subjects. SCN5A-positive patients exhibited a larger epicardial AS area, more prolonged electrograms and more frequently observed non-invasive late potentials. The presence of an SCN5A mutation explained >26% of the variation in the epicardial AS area and was the strongest predictor of a large epicardial area.
CONCLUSION: In BrS, the genetic background is the main determinant for the extent of the electrophysiological abnormalities. SCN5A mutation carriers exhibit more pronounced epicardial electrical abnormalities and a more aggressive clinical presentation. These results contribute to the understanding of the genetic determinants of the BrS phenotypic expression and provide possible explanations for the varying degrees of disease expression.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Brugada syndrome; Epicardial arrhythmogenic substrate; Genotype; Phenotype; Predictors; SCN5A

Year:  2021        PMID: 33221895      PMCID: PMC7955973          DOI: 10.1093/eurheartj/ehaa942

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  31 in total

1.  Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients.

Authors:  Jeroen P P Smits; Lars Eckardt; Vincent Probst; Connie R Bezzina; Jean Jacques Schott; Carol Ann Remme; Wilhelm Haverkamp; Günter Breithardt; Denis Escande; Eric Schulze-Bahr; Hervé LeMarec; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2002-07-17       Impact factor: 24.094

2.  Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.

Authors:  Josep Brugada; Carlo Pappone; Antonio Berruezo; Gabriele Vicedomini; Francesco Manguso; Giuseppe Ciconte; Luigi Giannelli; Vincenzo Santinelli
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-08-19

3.  Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry.

Authors:  Kenichiro Yamagata; Minoru Horie; Takeshi Aiba; Satoshi Ogawa; Yoshifusa Aizawa; Tohru Ohe; Masakazu Yamagishi; Naomasa Makita; Harumizu Sakurada; Toshihiro Tanaka; Akihiko Shimizu; Nobuhisa Hagiwara; Ryoji Kishi; Yukiko Nakano; Masahiko Takagi; Takeru Makiyama; Seiko Ohno; Keiichi Fukuda; Hiroshi Watanabe; Hiroshi Morita; Kenshi Hayashi; Kengo Kusano; Shiro Kamakura; Satoshi Yasuda; Hisao Ogawa; Yoshihiro Miyamoto; Jamie D Kapplinger; Michael J Ackerman; Wataru Shimizu
Journal:  Circulation       Date:  2017-03-24       Impact factor: 29.690

4.  Electroanatomic and Pathologic Right Ventricular Outflow Tract Abnormalities in Patients With Brugada Syndrome.

Authors:  Maurizio Pieroni; Pasquale Notarstefano; Antonio Oliva; Oscar Campuzano; Pasquale Santangeli; Monica Coll; Martina Nesti; Andrea Carnevali; Aureliano Fraticelli; Anna Iglesias; Simone Grassi; Ramon Brugada; Leonardo Bolognese
Journal:  J Am Coll Cardiol       Date:  2018-12-04       Impact factor: 24.094

Review 5.  Beyond the One Gene-One Disease Paradigm: Complex Genetics and Pleiotropy in Inheritable Cardiac Disorders

Authors:  Marina Cerrone; Carol Ann Remme; Rafik Tadros; Connie R Bezzina; Mario Delmar
Journal:  Circulation       Date:  2019-08-12       Impact factor: 29.690

6.  Slow conduction in the infarcted human heart. 'Zigzag' course of activation.

Authors:  J M de Bakker; F J van Capelle; M J Janse; S Tasseron; J T Vermeulen; N de Jonge; J R Lahpor
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

7.  Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation.

Authors:  Richard C Saumarez; Lidia Chojnowska; Richard Derksen; Mariusz Pytkowski; Maciej Sterlinski; Christopher L-H Huang; Nicolas Sadoul; Richard N W Hauer; Witold Ruzyłło; Andrew A Grace
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

Review 8.  Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

Authors:  Charles Antzelevitch; Bence Patocskai
Journal:  Curr Probl Cardiol       Date:  2015-06-11       Impact factor: 5.200

9.  Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome.

Authors:  Ghayath Baroudi; Carlo Napolitano; Silvia G Priori; Alessandro Del Bufalo; Mohamed Chahine
Journal:  Can J Cardiol       Date:  2004-03-15       Impact factor: 5.223

10.  Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome.

Authors:  S Mohsen Hosseini; Raymond Kim; Sharmila Udupa; Gregory Costain; Rebekah Jobling; Eriskay Liston; Seema M Jamal; Marta Szybowska; Chantal F Morel; Sarah Bowdin; John Garcia; Melanie Care; Amy C Sturm; Valeria Novelli; Michael J Ackerman; James S Ware; Ray E Hershberger; Arthur A M Wilde; Michael H Gollob
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

View more
  13 in total

1.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Back Sternick Eduardo; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong-Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti Mac Intyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Pablo Ochoa Juan; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  J Arrhythm       Date:  2022-05-31

2.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Eduardo Back Sternick; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti MacIntyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Juan Pablo Ochoa; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  Europace       Date:  2022-09-01       Impact factor: 5.486

3.  CLIN_SKAT: an R package to conduct association analysis using functionally relevant variants.

Authors:  Amrita Chattopadhyay; Ching-Yu Shih; Yu-Chen Hsu; Jyh-Ming Jimmy Juang; Eric Y Chuang; Tzu-Pin Lu
Journal:  BMC Bioinformatics       Date:  2022-10-23       Impact factor: 3.307

4.  Evaluating the Use of Genetics in Brugada Syndrome Risk Stratification.

Authors:  Michelle M Monasky; Emanuele Micaglio; Emanuela T Locati; Carlo Pappone
Journal:  Front Cardiovasc Med       Date:  2021-04-21

5.  Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.

Authors:  Carlo Pappone; Giuseppe Ciconte; Emanuele Micaglio; Michelle M Monasky
Journal:  Eur Heart J       Date:  2021-03-31       Impact factor: 29.983

Review 6.  The Mechanism of Ajmaline and Thus Brugada Syndrome: Not Only the Sodium Channel!

Authors:  Michelle M Monasky; Emanuele Micaglio; Sara D'Imperio; Carlo Pappone
Journal:  Front Cardiovasc Med       Date:  2021-12-23

7.  Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome.

Authors:  Anastasia K Zaytseva; Artem M Kiselev; Alexander S Boitsov; Yulia V Fomicheva; Georgii S Pavlov; Boris S Zhorov; Anna A Kostareva
Journal:  Biochem Biophys Rep       Date:  2022-03-11

Review 8.  Brugada Syndrome in Women: What Do We Know After 30 Years?

Authors:  Estefanía Martínez-Barrios; Elena Arbelo; Sergi Cesar; José Cruzalegui; Victoria Fiol; Nuria Díez-Escuté; Clara Hernández; Ramon Brugada; Josep Brugada; Oscar Campuzano; Georgia Sarquella-Brugada
Journal:  Front Cardiovasc Med       Date:  2022-04-11

9.  Commentary: Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome.

Authors:  Michelle M Monasky; Carola Rutigliani; Emanuele Micaglio; Carlo Pappone
Journal:  Front Physiol       Date:  2021-06-09       Impact factor: 4.566

10.  Does function trump bioinformatics in Brugada syndrome-associated SCN5A mutation calling? Patients, computers, and patches.

Authors:  Arthur A M Wilde; Cheng-I Wu
Journal:  Eur Heart J       Date:  2021-07-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.